Pages that link to "Q34233431"
The following pages link to Lysophosphatidic acid and ovarian cancer: a paradigm for tumorogenesis and patient management. (Q34233431):
Displaying 11 items.
- NHERF2 specifically interacts with LPA2 receptor and defines the specificity and efficiency of receptor-mediated phospholipase C-beta3 activation (Q24563311) (← links)
- Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma (Q24796051) (← links)
- LPA Induces Colon Cancer Cell Proliferation through a Cooperation between the ROCK and STAT-3 Pathways (Q35791590) (← links)
- Lysophosphatidic acid (LPA)-induced vasodilator-stimulated phosphoprotein mediates lamellipodia formation to initiate motility in PC-3 prostate cancer cells (Q37004375) (← links)
- Mechanisms linking obesity and cancer (Q37154242) (← links)
- Effects of lysophosphatidic acid on human colon cancer cells and its mechanisms of action (Q39795744) (← links)
- Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer (Q40541052) (← links)
- Lysophosphatidic Acid Inhibits Apoptosis Induced by Cisplatin in Cervical Cancer Cells (Q41947077) (← links)
- Quantification of phosphatidic acid and lysophosphatidic acid by HPLC with evaporative light-scattering detection (Q44300065) (← links)
- Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells (Q45142292) (← links)
- In vitro genetic screen identifies a cooperative role for LPA signaling and c-Myc in cell transformation. (Q46397627) (← links)